ASTERASYS CO., LTD. – Trademark Portfolio

Entity Type: 03

ASTERASYS CO., LTD. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 4 are pending. Notable registered marks include COOLFASE and B BELLELUMIE. The owner is based in Seoul.

1005, 25 Seongsuil-ro

4-gil, Seongdong-gu,

Seoul 04781 , KR

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ASTERASYS CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (6 filings)

Surgical, medical, dental and veterinary apparatus and instruments

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does ASTERASYS CO., LTD. have?

ASTERASYS CO., LTD. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 pending, 1 abandoned.

What trademark classes does ASTERASYS CO., LTD. file in?

ASTERASYS CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ASTERASYS CO., LTD.'s most well-known trademarks?

ASTERASYS CO., LTD.'s registered trademark portfolio includes well-known marks such as COOLFASE and B BELLELUMIE. These are among 2 currently registered trademarks in the portfolio.

What is ASTERASYS CO., LTD.'s trademark registration success rate?

ASTERASYS CO., LTD. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 4 applications are pending review.